Zacks.com featured highlights include Flex, CVS Health, Urban Outfitters and Exelixis

13.06.25 10:51 Uhr

Werte in diesem Artikel
Aktien

58,50 EUR 1,69 EUR 2,97%

35,15 EUR -0,24 EUR -0,68%

58,74 EUR -0,52 EUR -0,88%

Indizes

PKT PKT

19.406,8 PKT -255,7 PKT -1,30%

17.088,7 PKT 69,1 PKT 0,41%

2.927,4 PKT -32,7 PKT -1,10%

5.977,0 PKT -68,3 PKT -1,13%

935,5 PKT -8,9 PKT -0,94%

For Immediate ReleaseChicago, IL – June 13, 2025 – Stocks in this week’s article are Flex Ltd. FLEX, CVS Health CVS, Urban Outfitters URBN and Exelixis EXEL.4 Attractive GARP Picks for Your Portfolio Based on PEG RatiosIn the equity market, investments always need to be prudently hedged to overcome uncertainties and limit losses related to external shocks. A question that often arises is whether one should resort to a value strategy that seeks discounted stocks or opt for growth investing in times of extreme market instability.The investing track of the Oracle of Omaha over the past few decades and his gradual shift from being a pure-play value investor to a GARP (growth at a reasonable price) investor might give us all the answers.Several stocks that have surged significantly in the recent past show an overwhelming success of this hybrid investing strategy over pure-play value and growth investments. Here, we will discuss the success of four such stocks. These are Flex Ltd., CVS Health, Urban Outfitters and Exelixis.More on GARPThe GARP theory enables strategic mingling of growth and value-investing principles, which gives us a hybrid strategy by utilizing the best features of both. What GARPers look for is whether or not the stocks are somewhat undervalued and have solid, sustainable growth potential (Investopedia).PEG Ratio and GARPGARP investing gives priority to one of the popular value metrics — the price/earnings growth (PEG) ratio. Although it is categorized under value investing, this strategy follows the principles of both growth and value investing.The PEG ratio is defined as (Price/ Earnings)/Earnings Growth RateIt relates stocks' P/E ratio with their future earnings growth rates.While P/E alone gives an idea of stocks that are trading at a discount, PEG, while adding the growth element to it, helps identify stocks with solid future potential.A lower PEG ratio, preferably less than 1, is always better for GARP investors.Say, for example, if a stock's P/E ratio is 10 and the expected long-term growth rate is 15%, the company's PEG will come down to 0.66, a ratio indicating both undervaluation and future growth potential.Unfortunately, this ratio is often neglected due to investors' limitations in calculating the future earnings growth rate of a stock.There are some drawbacks to using the PEG ratio though. It does not consider the very common situation of changing growth rates, such as the forecast of the first three years at a very high growth rate, followed by a sustainable but lower growth rate over the long term.Hence, PEG-based investing can be even more rewarding if some other relevant parameters are also taken into consideration.Our PicksHere are the four stocks that qualified the screening:Flex: This Singapore-based company has a diverse workforce across 30 countries and offers advanced manufacturing solutions and additional value to customers through a wide array of services, including design and engineering, component services, rapid prototyping, fulfilment, and circular economy solutions. Flex is gaining from a growing intellectual property (IP) portfolio, new design wins and strategic acquisitions.FLEX stock can be an impressive GARP investment pick with its Zacks Rank #2 and a Value Score of A. Apart from a discounted PEG and P/E, Flex also has an impressive long-term historical earnings growth rate of 35.1%.You can see the complete list of today's Zacks #1 Rank stocks here.CVS Health: Headquartered in Woonsocket, RI, this is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. CVS Health is investing in advanced technological capabilities to cut down costs and improve customer experience. Improved Medicare Advantage star ratings for the 2025 payment year are a positive development for the company.CVS can also be an impressive GARP investment pick with its Zacks Rank #2 and a Value Score of A. Apart from a discounted PEG and P/E, CVS Health also has a solid long-term expected growth rate of 11.4%.Urban Outfitters: Based in Philadelphia, PA, Urban Outfitters is a lifestyle specialty retailer that offers fashion apparel and accessories, footwear, home décor and gift products. The company's merchandise is generally sold directly to consumers through stores, catalogs, call centers and e-commerce platforms.Apart from a discounted PEG and P/E, Urban Outfitters has a Value Score of A and holds a Zacks Rank #1. URBN stock also has a 20% earnings growth rate for the last five years.Exelixis: This Alameda, CA-based oncology-focused biotechnology company primarily focuses on the discovery, development and commercialization of new drugs for the treatment of difficult-to-treat cancers. Exelixis has collaborations with several leading pharmaceutical companies such as Bristol-Myers Squibb, Merck and Daiichi Sankyo Company for various compounds and programs in its portfolio.The stock can be an impressive value investment pick with its Zacks Rank #2 and a Value Score of B. Apart from a discounted PEG and P/E, the stock also has an impressive long-term expected earnings growth rate of 21.2%.The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.Click here to sign up for a free trial to the Research Wizard today.For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/2496778/4-attractive-garp-picks-for-your-portfolio-based-on-peg-ratioDisclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.About Screen of the WeekZacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine.  But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.Strong Stocks that Should Be in the NewsMany are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.Follow us on Twitter:  https://www.twitter.com/zacksresearchJoin us on Facebook:  https://www.facebook.com/ZacksInvestmentResearchZacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.Contact: Jim GiaquintoCompany: Zacks.comPhone: 312-265-9268Email: pr@zacks.comVisit: https://www.zacks.com/Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.5% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report CVS Health Corporation (CVS): Free Stock Analysis Report Urban Outfitters, Inc. (URBN): Free Stock Analysis Report Exelixis, Inc. (EXEL): Free Stock Analysis Report Flex Ltd. (FLEX): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: CVS Health und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf CVS Health

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf CVS Health

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu CVS Health Corp

Wer­bung

Analysen zu CVS Health Corp

DatumRatingAnalyst
05.06.2019CVS Health BuyStandpoint Research
15.04.2019CVS Health PerformOppenheimer & Co. Inc.
12.04.2019CVS Health Market PerformBMO Capital Markets
18.12.2018CVS Health OverweightBarclays Capital
26.10.2018CVS Health Peer PerformWolfe Research
DatumRatingAnalyst
05.06.2019CVS Health BuyStandpoint Research
12.04.2019CVS Health Market PerformBMO Capital Markets
18.12.2018CVS Health OverweightBarclays Capital
30.01.2018CVS Health Strong BuyNeedham & Company, LLC
02.01.2018CVS Health BuyNeedham & Company, LLC
DatumRatingAnalyst
15.04.2019CVS Health PerformOppenheimer & Co. Inc.
26.10.2018CVS Health Peer PerformWolfe Research
28.06.2017CVS Health HoldNeedham & Company, LLC
02.02.2017CVS Health NeutralRobert W. Baird & Co. Incorporated
22.06.2016CVS Health HoldDeutsche Bank AG
DatumRatingAnalyst
25.07.2005Update Longs Drug Stores Corp.: UnderperformBear Stearns

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für CVS Health Corp nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen